AI
| Followers | 48 |
| Posts | 12087 |
| Boards Moderated | 0 |
| Alias Born | 09/12/2017 |
Saturday, December 26, 2020 2:39:01 PM
Looks like a total contradiction or lie in the same paragraph to me.
So is this CYDY quote a lie or not?
August 12th---
https://www.transcriptshare.com/s/cydy/conference-call-august-12
Update on August 17th (Five days later)---
CytoDyn Requests Covid-19 Emergency Use Approval For Leronlimab
Late-stage biotech CytoDyn Inc (CYDY) has announced that it has provided its Top-line Report from its recently completed Phase 2 trial of leronlimab for COVID-19 patients with mild-to-moderate symptoms to the U.S. Food and Drug Administration (FDA), and requested emergency use approval.
In addition, CytoDyn has sent the report to the regulatory authorities in Mexico and hopes to obtain emergency use approval from the MHRA in the U.K., EMA in the European Union, as well as the regulatory authorities in the Philippines.
https://finance.yahoo.com/news/cytodyn-requests-covid-19-emergency-125739300.html
So is this CYDY quote a lie or not?
August 12th---
https://www.transcriptshare.com/s/cydy/conference-call-august-12
Update on August 17th (Five days later)---
CytoDyn Requests Covid-19 Emergency Use Approval For Leronlimab
Late-stage biotech CytoDyn Inc (CYDY) has announced that it has provided its Top-line Report from its recently completed Phase 2 trial of leronlimab for COVID-19 patients with mild-to-moderate symptoms to the U.S. Food and Drug Administration (FDA), and requested emergency use approval.
In addition, CytoDyn has sent the report to the regulatory authorities in Mexico and hopes to obtain emergency use approval from the MHRA in the U.K., EMA in the European Union, as well as the regulatory authorities in the Philippines.
https://finance.yahoo.com/news/cytodyn-requests-covid-19-emergency-125739300.html
